Sign in to follow
Search Results

0 results for 'Novartis'

You can use to get even better search results
March 19, 2024 | The Recorder

Despite Cuts, Fenwick Sees Revenue Growth and Remains Bullish on Tech Business Bounceback

"Some uncertainty remains. But it will come back, and come back stronger," said firm chair Richard Dickson about the firm's scope of work. "We just don't know exactly when."
5 minute read
February 12, 2024 | The American Lawyer

Deal Watch: Wachtell, Paul Weiss and V&E Lead $26B Oil Merger as Deal Activity Soars

Energy and life sciences continue to lead the way in deal activity, but tech and other recently nascent sectors are showing signs of life.
12 minute read
January 19, 2024 | New Jersey Law Journal

Big Law Squares Off in Battle Over Prescription Drug Prices

Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.
5 minute read
December 08, 2023 | New York Law Journal

Juror Attitudes Toward Pharmaceutical Companies

In February 2023, the DOAR Research Center sought to shed light on changing attitudes toward the pharmaceutical industry by conducting a survey, which questioned respondents on their opinions of the pharmaceutical industry and their COVID-19 experiences. This article highlights the results of the survey.
8 minute read
November 20, 2023 | Corporate Counsel

The 2023 WIPL Awards: In-House Thought Leadership

For this award, Corporate Counsel recognizes women who focus on how true leadership can change the world.
15 minute read
Law Journal Press | Digital Book Wrongful Use of Civil Proceedings and Related Torts in Pennsylvania, Second Edition Authors: George Bochetto, David P. Heim, John A. O’Connell, Robert S. Tintner View this Book

View more book results for the query "Novartis"

July 24, 2023 | The Recorder

Deal Watch: Will IPOs Strike Back This Year?

Novartis has agreed to purchase DTx Pharma for $1 billion. DTx Pharma, which is based in San Diego, was represented by a Wilson Sonsini Goodrich & Rosati team.
7 minute read
July 24, 2023 | The American Lawyer

Deal Watch: Will IPOs Strike Back This Year?

Some dealmakers see signs that capital markets work could turn around this year.
7 minute read
June 29, 2023 | Corporate Counsel

UBS General Counsel Absorbs Credit Suisse GC Role Amid Cuts

The move comes as Credit Suisse's GC exits the bank amid a sweep of cuts at the beleaguered Swiss bank that have followed its sale to UBS.
3 minute read
June 19, 2023 | Law.com

The UK Legal Industry's Biggest Overseas Buyers? 2 Tax Havens

As major companies shifted their HQs to tax havens, law firm export revenues went with them—now, interest in these small European nations is burgeoning.
7 minute read
June 08, 2023 | National Law Journal

Congress Should Consider Patent Changes to Keep Up With AI, Lawmakers Say

Senate Judiciary panel cites competition from China and discusses need for an intellectual property agency dedicated to AI technology.
4 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now

    • Countdown to Compliance: SEC Private Fund Reforms

      Brought to you by Ontra

      Download Now